Skip to content

Gastrointestinal Tolerance And General Health Status Of Healthy Term Infants Fed A New Infant Formula

Gastrointestinal Tolerance And General Health Status Of Healthy Term Infants Fed A New Infant Formula: A Prospective, Observational Cohort Study In China

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01370967
Enrollment
460
Registered
2011-06-10
Start date
2011-07-31
Completion date
2013-07-31
Last updated
2013-12-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy

Keywords

infant, term birth, human milk, infant formula, breast feeding, bottle feeding, gastrointestinal tract, quality of life, infant development

Brief summary

The purpose of this study is to assess stool consistency, in combination with additional health-related parameters including gastrointestinal tolerance and health-related quality of life, in a large sample of Chinese infants. We will also assess the timing of, frequency, and reasons for changes in the choice of formula or method of feeding among infants in this sample, as well as incidence of common infant illness and associated healthcare usage. Anthropometric measures and the frequency and duration of physician- and parent-reported gastrointestinal and other adverse events will be evaluated.

Detailed description

Parents / legally acceptable representatives of eligible infants will be invited to volunteer.

Interventions

OTHERStudy formula feeding

Infants who are exclusively fed the new study formula at time of enrollment

OTHERHuman milk feeding

Infants who are exclusively fed human milk at time of enrollment

OTHERMixed feeding

Infants who are exclusively fed human milk and the new study formula at time of enrollment

Sponsors

Société des Produits Nestlé (SPN)
Lead SponsorINDUSTRY

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
35 Days to 49 Days
Healthy volunteers
Yes

Inclusion criteria

* Healthy, term (37-42 weeks gestation), singleton infant at birth. * Post-natal age between 35 and 49 days (date of birth = day 0) at time of study entry. * At enrollment, weight-for-age ≥ 5th and ≤ 95th percentile according to World Health Organization growth tables / charts.

Exclusion criteria

* Infants who are consuming any types/brands of formula other than the new study formula (either exclusively or in a mixed feeding regimen) at time of study enrollment. * Suspected or documented severe acute or chronic medical or psychiatric condition or laboratory abnormality that may increase the risk associated with study participation or may interfere with the interpretation of study results, and in the judgment of the investigator, would make the infant inappropriate for entry into the study.

Design outcomes

Primary

MeasureTime frame
Infant stool consistency and frequency (assessed using a 3-day stool diary)Baseline

Secondary

MeasureTime frame
Infant gastrointestinal tolerance (assessed using a validated, interviewer-assisted parent questionnaire)Baseline
Infant and parent health-related quality of life (assessed using validated parent questionnaires)Baseline

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 12, 2026